Researchers Database

TEI RINNA

Affiliation： Department of Pulmonary Medicine and Clinical Immunology

Last Updated :2026/04/21

Original paper

Unclear

TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung., Tei Rinna;Iijima Koji;Matsumoto Koji;Kobayashi Takao;Lama Jyoti;Jacobsen Elizabeth A;Kita Hirohito, The Journal of allergy and clinical immunology, 149(3), 1044-1059.e5, 2022
DOI Permalink

Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens., Block Katharine E;Iijima Koji;Pierson Mark J;Walsh Daniel A;Tei Rinna;Kucaba Tamara A;Xu Julie;Khan Mohammad Haneef;Staley Christopher;Griffith Thomas S;McSorley Henry J;Kita Hirohito;Jameson Stephen C, Nature immunology, 23(12), 1703-1713, 21 Nov. 2022
DOI

Dysregulated metabolic pathways of pulmonary fibrosis and the lipids associated with the effects of nintedanib therapy., Shimizu Yasuo;Horibata Yasuhiro;Domae Mariko;Nakamura Yusuke;Yokoyama Tatsuya;Arai Ryo;Shiobara Taichi;Takemasa Akihiro;Koike Ryosuke;Uchida Nobuhiko;Masawa Meitetsu;Tei Rinna;Watanabe Taiji;Morita Hiroko;Miyoshi Masaaki;Soda Sayo;Niho Seiji;Igami Ko;Sugimoto Hiroyuki, Respiratory research, 26(1), 166, 28 Apr. 2025
DOI

Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study., Kushima Yoshitomo;Shimizu Yasuo;Arai Ryo;Chibana Kazuyuki;Shimizu Yuka;Amagai Masahiro;Takemasa Akihiro;Ikeda Naoya;Masawa Meitetsu;Kushima Atsushi;Okutomi Hiroaki;Nakamura Yusuke;Tei Rinna;Ando Yuki;Yazawa Nana;Goto Yuto;Haruyama Yasuo;Yukawa Tatsuo;Niho Seiji, Frontiers in allergy, 6, 1537501, 17 Mar. 2025
DOI